Document is current
Any future updates will be listed below
-
Authors
Tubbs, Justin D. https://orcid.org/0000-0002-6671-6816
Mallard, Travis T. https://orcid.org/0000-0002-3265-3001
Dalby, Maria
Jiang, Yunxuan
Lee, Younga H. https://orcid.org/0000-0001-7517-6594
Choi, Karmel W.
Ge, Tian
Plath, Niels
Hammer-Helmich, Lene https://orcid.org/0000-0001-8962-6250
Granka, Julie M.
,
Grotzinger, Andrew D. https://orcid.org/0000-0001-7852-9244
Hinds, David https://orcid.org/0000-0002-4911-803X
Smoller, Jordan W. https://orcid.org/0000-0002-0381-6334
Buckholtz, Joshua W.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (T32HG010464)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K08MH135343)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K08MH135343)
The AFFECT study was funded by H. Lundbeck A/S and the Milken Institute.
23andMe Inc.
- License Information
-
More Information
Article History
Received: 20 May 2025
Revised: 11 May 2026
Accepted: 16 June 2026
First Online: 7 July 2026
Competing interests
: YJ, JMG, DH, and members of the 23andMe Research Group are employed by and hold stock or stock options in 23andMe, Inc. MD and NP are employees of MUNA Therapeutics. LH-H is an employee of H Lundbeck A/S JWS is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity) and has received an honorarium for an internal seminar Tempus Labs. All other authors report no biomedical financial interests or potential conflicts of interest.
